Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06340503 · ClinicalTrials.gov registry record · NA
Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors
A NA study of Breast Cancer and Colon Cancer, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06340503 is a NA study of Breast Cancer and Colon Cancer that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06340503, a NA study of Breast Cancer and Colon Cancer, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine whether using the physical activity index screener, exercise coaching, and self-monitoring will increase physical activity and reduce time spent sitting or being inactive in patients who had breast or colon cancer.
Conditions Studied
Interventions
- OTHER Interview
- DEVICE Research-grade accelerometer
- OTHER National Comprehensive Cancer Network (NCCN) Education Materials
- DEVICE Garmin Vivofit activity tracker
- OTHER Exercise Consultation Calls
Study Locations (1)
North Carolina
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-11-06 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06340503
The ClinicalTrials.gov registry entry for NCT06340503 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Interview is the first listed.
NCT06340503 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06340503 about?
NCT06340503 is a clinical study titled "Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors". The purpose of this research study is to determine whether using the physical activity index screener, exercise coaching, and self-monitoring will increase physical activity and reduce time spent sitting or being inactive in patients who had breast or colon cancer.
What is the current status of trial NCT06340503?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-11-06. Estimated completion is 2026-06.
What conditions does trial NCT06340503 study?
This clinical trial studies the following conditions: Breast Cancer, Colon Cancer.
What interventions are being tested in trial NCT06340503?
The interventions under investigation include: Interview (OTHER), Research-grade accelerometer (DEVICE), National Comprehensive Cancer Network (NCCN) Education Materials (OTHER), Garmin Vivofit activity tracker (DEVICE), Exercise Consultation Calls (OTHER).
Who is sponsoring clinical trial NCT06340503?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06340503 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.